載入...
Placebo-controlled trial of rituximab in IgM anti-myelin–associated glycoprotein neuropathy
OBJECTIVE: To determine whether rituximab 375 mg/m(2) was efficacious in patients with immunoglobulin M (IgM) anti-myelin–associated glycoprotein antibody demyelinating neuropathy (IgM anti-MAG demyelinating neuropathy). METHODS: Fifty-four patients with IgM anti-MAG demyelinating neuropathy were en...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Lippincott Williams & Wilkins
2013
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3721095/ https://ncbi.nlm.nih.gov/pubmed/23667063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e318296e92b |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|